This afternoon, a federal appeals court temporarily restored federal funding for stem cell research pending appeal of a U.S. District Court ruling of August 23 that halted such funding. The temporary lift of the injunction allows researchers to proceed with projects while the Obama administration prepares an appeal. To view the order and learn more about the case, see the Washington Post article published earlier today.
Many of our readers are involved in stem cell research, either as investigators or as members of an institutional review board (IRB). We are curious to hear what impact this case has had on your work. Are you involved in stem cell research? And if so, how have these recent developments affected your work?